UNC spinout raises $300K to build a better antibiotic
Startup Synereca Pharmaceuticals, a spinout from the University of North Carolina at Chapel Hill, has raised $300,000 as the company works on a way to make existing antibiotics work better. The company's technology could give new life to products whose effectiveness has been diminished by growing bacterial drug resistance.